JPWO2022259904A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022259904A5
JPWO2022259904A5 JP2023527625A JP2023527625A JPWO2022259904A5 JP WO2022259904 A5 JPWO2022259904 A5 JP WO2022259904A5 JP 2023527625 A JP2023527625 A JP 2023527625A JP 2023527625 A JP2023527625 A JP 2023527625A JP WO2022259904 A5 JPWO2022259904 A5 JP WO2022259904A5
Authority
JP
Japan
Prior art keywords
protease
fusion protein
protein substrate
measuring
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023527625A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022259904A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/022041 external-priority patent/WO2022259904A1/ja
Publication of JPWO2022259904A1 publication Critical patent/JPWO2022259904A1/ja
Publication of JPWO2022259904A5 publication Critical patent/JPWO2022259904A5/ja
Pending legal-status Critical Current

Links

JP2023527625A 2021-06-07 2022-05-31 Pending JPWO2022259904A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021095348 2021-06-07
PCT/JP2022/022041 WO2022259904A1 (ja) 2021-06-07 2022-05-31 プロテアーゼ活性測定用の融合タンパク質基質

Publications (2)

Publication Number Publication Date
JPWO2022259904A1 JPWO2022259904A1 (https=) 2022-12-15
JPWO2022259904A5 true JPWO2022259904A5 (https=) 2025-06-02

Family

ID=84424936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527625A Pending JPWO2022259904A1 (https=) 2021-06-07 2022-05-31

Country Status (2)

Country Link
JP (1) JPWO2022259904A1 (https=)
WO (1) WO2022259904A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
DE19920514A1 (de) * 1999-05-05 2000-11-16 Boehringer Ingelheim Pharma Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten
ATE488766T1 (de) * 2004-06-21 2010-12-15 Progenra Inc Diagnostik und screening-methode und kit in verbindung mit proteolytischer aktivität
CA2698362C (en) * 2007-09-04 2013-03-26 Sanofi-Aventis Identifying molecules that modulate protein- protein interactions using protease activated reporters
WO2011071956A2 (en) * 2009-12-07 2011-06-16 Synaptic Research, Llc Method for identification of protease activity inhibitors and assaying the presence of protease activity

Similar Documents

Publication Publication Date Title
Xiang et al. Complete protein linkage map of poliovirus P3 proteins: interaction of polymerase 3Dpol with VPg and with genetic variants of 3AB
Filomatori et al. A 5′ RNA element promotes dengue virus RNA synthesis on a circular genome
Latorre et al. Sendai virus Y proteins are initiated by a ribosomal shunt
Andino et al. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′‐end of viral RNA.
Friebe et al. Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication
Shi et al. Viral and cellular proteins involved in coronavirus replication
Isken et al. Complex signals in the genomic 3′ nontranslated region of bovine viral diarrhea virus coordinate translation and replication of the viral RNA
Fang et al. Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins 10 and 11/12 of Coronavirus infectious bronchitis virus is dispensable for viral replication in cultured cells
Ziebuhr et al. Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication
WO2015035452A1 (en) Bimolecular protease-based biosensor
Belov et al. Involvement of cellular membrane traffic proteins in poliovirus replication
JP2018518168A (ja) 電気化学バイオセンサー
CN113564149B (zh) 一种三联体融合蛋白及其在病毒自剪切蛋白酶抑制剂活性评估和筛选时的应用
Fletcher et al. The influence of viral coding sequences on pestivirus IRES activity reveals further parallels with translation initiation in prokaryotes
US20180127800A1 (en) Compositions and methods for identifying zika enzyme inhibitors
Vashist et al. La protein binds the predicted loop structures in the 3′ non-coding region of Japanese encephalitis virus genome: role in virus replication
Hass et al. Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome
JP2002542812A5 (https=)
JPWO2022259904A5 (https=)
Löhr et al. Yellow fever virus NS3 protease: peptide-inhibition studies
Huang et al. The 3′-terminal hexamer sequence of classical swine fever virus RNA plays a role in negatively regulating the IRES-mediated translation
Mori et al. Processing of capsid protein by cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells
Harpen et al. Mutational analysis reveals a noncontractile but interactive role of actin and profilin in viral RNA-dependent RNA synthesis
Lobigs Proteolytic processing of a Murray Valley encephalitis virus non-structural polyprotein segment containing the viral proteinase: accumulation of a NS3-4A precursor which requires mature NS3 for efficient processing
US20240368664A1 (en) Live yeast biosensors and methods of use thereof